Abstract: The present invention describes the identification, isolation and cloning of two human presenilin genes, PS-1 and PS-2, mutations in which lead to Familial Alzheimer's Disease. Also identified are presenilin homologue genes in mice, C. elegans and D. melanogaster. Transcripts and products of these genes are useful in detecting and diagnosing Alzheimer's disease, developing therapeutics for treatment of Alzheimer's disease, as well as the isolation and manufacture of the protein and the constructions of transgenic animals expressing the mutant genes.
Type:
Grant
Filed:
July 31, 1998
Date of Patent:
February 27, 2001
Assignees:
The Hospital for Sick Children, HSC Research and Development
Limited Partnership, The Governing Council of the University of Toronto
Inventors:
Peter H. St. George-Hyslop, Johanna M. Rommens, Paul E. Fraser
Abstract: The present invention describes the identification, isolation and cloning of two human presenilin genes, PS-1 and PS-2, mutations in which lead to Familial Alzheimer's Disease. Also identified are presenilin homologue genes in mice, C. elegans and D. melanogaster. Transcripts and products of these genes are useful in detecting and diagnosing Alzheimer's disease, developing therapeutics for treatment of Alzheimer's disease, as well as the isolation and manufacture of the protein and the constructions of transgenic animals expressing the mutant genes.
Type:
Grant
Filed:
January 26, 1996
Date of Patent:
November 16, 1999
Assignees:
The Hospital for Sick Children, HSC Research and Development Limited Partnership, The Governing Council of the University of Toronto
Inventors:
Peter H. St. George-Hyslop, Johanna M. Rommens, Paul E. Fraser